A detailed history of First Light Asset Management, LLC transactions in Centessa Pharmaceuticals PLC stock. As of the latest transaction made, First Light Asset Management, LLC holds 4,780,560 shares of CNTA stock, worth $74.1 Million. This represents 3.93% of its overall portfolio holdings.

Number of Shares
4,780,560
Previous 3,002,045 59.24%
Holding current value
$74.1 Million
Previous $33.9 Million 27.25%
% of portfolio
3.93%
Previous 2.65%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$8.04 - $11.87 $14.3 Million - $21.1 Million
1,778,515 Added 59.24%
4,780,560 $43.2 Million
Q1 2024

May 15, 2024

BUY
$6.73 - $12.2 $20.2 Million - $36.6 Million
3,002,045 New
3,002,045 $33.9 Million

Others Institutions Holding CNTA

About Centessa Pharmaceuticals plc


  • Ticker CNTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,339,296
  • Market Cap $1.46B
  • Description
  • Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor that is in Phase III clinical development for the treatment of autosomal dominant polycystic kidney disease; an...
More about CNTA
Track This Portfolio

Track First Light Asset Management, LLC Portfolio

Follow First Light Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Light Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on First Light Asset Management, LLC with notifications on news.